Phosphorylated KDR expression in endometrial cancer cells relates to HIF1alpha/VEGF pathway and unfavourable prognosis.

作者: Alexandra Giatromanolaki , , Michael I Koukourakis , Helen Turley , Efthimios Sivridis

DOI: 10.1038/MODPATHOL.3800579

关键词:

摘要: Vascular endothelial growth factor (VEGF) is a potent angiogenic for many malignant neoplasms exerting its function through activation of specific membrane receptors, that is, KDR/flk-1, residing in cells. Several recent reports indicate VEGF receptors are also expressed cancer cells, suggesting VEGF-originated cell reactions may parallel the response. Using novel monoclonal antibody, recognizing activated (phosphorylated) form KDR receptor (pKDR), we assessed expression pKDR normal and endometrium. A strong consistent cytoplasmic nuclear was noted normally cycling endometrium, including epithelial, stromal role menstrual cycle. Approximately, one-third 70 stage I endometrioid adenocarcinomas analysed exhibited an intense both cells peritumoral vessels. It such reactivity related directly to VEGF, VEGF/KDR complexes HIF1α (hypoxia inducible 1α) expression. Furthermore, significantly associated with poor prognosis. concluded pathway suggestive important biology this tissue. The unfavourable prognosis confers endometrial could be attributed activity, but direct effect on autocrine loop.

参考文章(38)
Anna Ottlecz, Paulo Ottino, George N Lambrou, Nicolas G Bazan, Haydee E P Bazan, Eileen Rojo, Joelle Finley, Hypoxia activates matrix metalloproteinase expression and the VEGF system in monkey choroid-retinal endothelial cells: Involvement of cytosolic phospholipase A2 activity. Molecular Vision. ,vol. 10, pp. 341- 350 ,(2004)
Michael I. Koukourakis, Rolf A. Brekken, Alexandra Giatromanolaki, Efthimios Sivridis, Philip E. Thorpe, Kevin C. Gatter, Vassilis Georgoulias, Stelios Kakolyris, Adrian L. Harris, Vascular Endothelial Growth Factor/KDR Activated Microvessel Density versus CD31 Standard Microvessel Density in Non-Small Cell Lung Cancer Cancer Research. ,vol. 60, pp. 3088- 3095 ,(2000)
D Stephen Charnock-Jones, Andrew M Sharkey, Christine A Boocock, Asif Ahmed, Robin Plevin, Napoleone Ferrara, Stephen K Smith, None, Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells. Biology of Reproduction. ,vol. 51, pp. 524- 530 ,(1994) , 10.1095/BIOLREPROD51.3.524
Rolf Mentlein, Frauke Forstreuter, Hubertus M. Mehdorn, Janka Held-Feindt, Functional significance of vascular endothelial growth factor receptor expression on human glioma cells. Journal of Neuro-oncology. ,vol. 67, pp. 9- 18 ,(2004) , 10.1023/B:NEON.0000021737.89357.CC
Michael Klagsbrun, Patricia A. D'Amore, Vascular endothelial growth factor and its receptors. Cytokine & Growth Factor Reviews. ,vol. 7, pp. 259- 270 ,(1996) , 10.1016/S1359-6101(96)00027-5
Stephen B Fox, Helen Turley, Michelle Cheale, Cristina Blázquez, Helen Roberts, Neil James, Nathan Cook, Adrian Harris, Kevin Gatter, Phosphorylated KDR is expressed in the neoplastic and stromal elements of human renal tumours and shuttles from cell membrane to nucleus. The Journal of Pathology. ,vol. 202, pp. 313- 320 ,(2004) , 10.1002/PATH.1520
Johannes Waltenberger, Ulrike Mayr, Siegwald Pentz, Vinzenz Hombach, Functional Upregulation of the Vascular Endothelial Growth Factor Receptor KDR by Hypoxia Circulation. ,vol. 94, pp. 1647- 1654 ,(1996) , 10.1161/01.CIR.94.7.1647